At AbbVie, we have the expertise of a proven pharmaceutical leader and the focus and passion of an entrepreneur and innovator. The result is something rare in health care today – a global biopharmaceutical company that has the ability to discover and advance innovative therapies and meet the health needs of people and societies around the globe.
The Pharmaceuticals Division, our largest in terms of sales, is focused on the following areas in which we aim to make decisive contributions to medical progress: oncology, cardiology and hematology, gynecology, neurology, infectious diseases, men’s health, ophthalmology, and diagnostic imaging.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.
MSD is a global healthcare leader working to address unmet health needs. We provide innovative medicines, vaccines, biologic therapies and animal health products to help improve health and well-being. We work with customers in 140 countries to deliver broad-based healthcare solutions. The company is known as Merck in the United States and Canada. Everywhere else, we are known as MSD.
Dr. Falk Pharma GmbH is an independent family firm based in Freiburg im Breisgau. In spite of its international presence, Dr. Falk Pharma and its 200 staff are still closely linked with the Freiburg region and the University of Freiburg. Our company specializes in the development and sales of medication for indications in hepatology and gastroenterology. These, mainly prescription drugs, are sold not only in Germany but also in a further 65 countries, often in co-operation with local partners but in some cases also via our own subsidiary companies.